WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
26.67
+0.07 (+0.26%)
At close: 4:17PM EST
Stock chart is not supported by your current browser
Previous Close26.60
Open26.79
Bid26.71 x 0
Ask26.74 x 0
Day's Range26.53 - 27.46
52 Week Range18.23 - 70.98
Volume1758821
Avg. Volume2,241,284
Market Cap9.3B
Beta (3Y Monthly)3.80
PE Ratio (TTM)N/A
EPS (TTM)-5.76
Earnings DateFeb 12, 2020 - Feb 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.84
  • Bruce Linton on new Canopy Growth CEO: 'He's a perfect pick'
    Yahoo Finance Video

    Bruce Linton on new Canopy Growth CEO: 'He's a perfect pick'

    Canopy Growth shares are surging today, after the cannabis giant announced it has landed a new CEO. Former Canopy Growth Co-CEO and Vireo Health Executive Chairman Bruce Linton joins Yahoo Finance's Zack Guzman and Brian Cheung, along with Campus Reform Editor-in-Chief Cabot Phillip, to discuss the company's leadership shakeup and more.

  • Top Trending: White Castle burger recall, North Korea’s new resort, Canopy Growth’s new CEO
    Yahoo Finance Video

    Top Trending: White Castle burger recall, North Korea’s new resort, Canopy Growth’s new CEO

    Yahoo Finance’s Adam Shapiro covers the top trending stories on On The Move.

  • Qorvo gets double upgrade to buy from BofAML
    Yahoo Finance Video

    Qorvo gets double upgrade to buy from BofAML

    Qorvo gets a double upgrade from Bank of America Merrill Lynch to buy and Canopy Growth names a new CEO. Yahoo Finance's Ines Ferre reports from the floor of the New York Stock Exchange.

  • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lipocine, Armstrong Flooring, Wanda Sports Group, and Canopy Growth and Encourages Investors to Contact the Firm
    PR Newswire

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lipocine, Armstrong Flooring, Wanda Sports Group, and Canopy Growth and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Lipocine, Inc. (NASDAQ: LPCN), Armstrong Flooring, Inc (NYSE: AFI), Wanda Sports Group Company Limited (NASDAQ: WSG), and Canopy Growth Corporation (NYSE: CGC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

  • CNW Group

    Media Advisory - Canopy Growth Brings Chocolate Back to Smiths Falls: Official Chocolate Factory Ribbon Cutting

    Media Advisory - Canopy Growth Brings Chocolate Back to Smiths Falls: Official Chocolate Factory Ribbon Cutting

  • Cannabis stocks slammed as analysts say Canopy’s new CEO faces big challenges
    MarketWatch

    Cannabis stocks slammed as analysts say Canopy’s new CEO faces big challenges

    Cannabis stocks fell Tuesday, as analysts weighing in on Canopy Growth’s new chief executive took a cautious stance, highlighting the continuing challenges facing the company.

  • Barrons.com

    Marijuana Stock Canopy Growth’s New CEO Isn’t a Reason to Buy Now

    Constellation Brands Chief Financial Officer David Klein will be Canopy Growth’s next CEO. But that doesn’t mean it’s time to buy the stock, according to an analyst at MKM Partners.

  • Cannabis market leader Canopy Growth names Constellation Brands’ CFO as its new CEO
    MarketWatch

    Cannabis market leader Canopy Growth names Constellation Brands’ CFO as its new CEO

    Canopy Growth Corp. said Monday it has named David Klein, currently chief financial officer at its biggest shareholder, Constellation Brands Inc., as its new chief executive, taking over from Mark Zekulin on January 14.

  • Barrons.com

    Canopy Growth Jumps 14%, and Two More Numbers to Know

    STOCKSTOWATCHTODAY BLOG Three numbers to start your day: Paul Volker Was 92 When he Passed Away on Sunday Volker was the former chairman of the Federal Reserve and a towering figure in finance. He famously took over America’s central bank in 1979 when inflation was well past double digits and managed to tame price increases.

  • Investopedia

    Stocks Hold Against Resistance

    We look at the balance of power indicator using Amgen as an example and discuss a potential move higher for cannabis stocks.

  • Former Canopy Growth co-CEO calls company's choice to replace him the 'perfect pick'
    Yahoo Finance

    Former Canopy Growth co-CEO calls company's choice to replace him the 'perfect pick'

    Even after being fired as Canopy Growth's co-CEO earlier this year, Bruce Linton is applauding the company's pick to replace him.

  • Canopy Growth Soars As Constellation Brands CFO Named CEO Of Marijuana Company
    Investor's Business Daily

    Canopy Growth Soars As Constellation Brands CFO Named CEO Of Marijuana Company

    Canopy Growth soared Monday on the news Constellation Brands CFO David Klein will become CEO of the troubled Canadian cannabis producer.

  • Benzinga

    Canopy Growth Analyst Says Constellation Brands Likely To Bid On Cannabis Company's Equity

    Canopy Growth (NYSE: CGC) shares jumped Monday when the company announced the appointment of Constellation Brands (NYSE: STZ) CFO David Klein as the cannabis company's CEO. Cantor Fitzgerald’s Pablo Zuanic reiterated a Neutral rating on Canopy Growth with a CA$18.90 ($14.27) price target. Zuanic was surprised it has taken this long for Canopy Growth to hire a new CEO after Bruce Linton's departure, the analyst said in a Monday note.

  • Barrons.com

    The Dow Is Falling 72 Points Because China Tariffs Could Happen

    The three major U.S. stock market indexes fell as investors fear that there won’t be enough progress made in trade talks between the U.S. and China to prevent tariffs that are scheduled for Dec. 15 from taking effect.

  • Barrons.com

    Canopy Growth Has a New CEO. Here’s What He Needs to Do Now.

    A top task facing Canopy Growth’s newly-announced chief executive will be to control the cannabis company’s swelling expenses. Good thing that David Klein has been the financial chief at the pot producer’s big shareholder, (STZ) because his bud-counting skills will be tested by the costs of the new beverages, vapes and chocolates that Canopy starts selling in Canada next month. Investors seem happy that a financial guy is taking charge of (WEED) (ticker: CGC), whose founder Bruce Linton was forced out in July by Constellation (STZ) after the pot pioneer’s losses ballooned.

  • Barrons.com

    Marijuana Stock Canopy Growth Is Soaring Because It Finally Has a New CEO

    David Klein, executive vice president and chief financial officer of Constellation Brands, will succeed Canopy Growth CEO Mark Zekulin on Jan. 14. The news ends a search that began in early July.

  • Constellation Exec Named Canopy CEO as Takeover Odds Grow
    Bloomberg

    Constellation Exec Named Canopy CEO as Takeover Odds Grow

    (Bloomberg) -- Canopy Growth Corp., the world’s most valuable cannabis company, has appointed Constellation Brands Inc.’s finance head as its chief executive officer, raising the odds that the alcohol giant will buy Canopy outright.David Klein, currently chief financial officer of Constellation and chair of Canopy’s board of directors, will become the pot company’s CEO effective Jan. 14, Canopy announced Monday. Constellation owns approximately 35% of Canopy.Klein will replace Mark Zekulin, who has been leading the company as its sole CEO since Bruce Linton was forced out of his co-CEO role in July amid increasing pressure to turn a profit. Canopy shares rose as much as 13% in Toronto, while Constellation dipped 1.3% in New York.“Canopy Growth sits at the forefront of one of the most exciting new market opportunities in our lifetime,” Klein said in a statement. “I look forward to working with the team to build on the foundation that has been laid, to develop brands that strongly resonate with consumers, and to capture the market opportunity before us.”In an interview at Bloomberg’s New York office, Linton said he believes Constellation is preparing to acquire the remainder of Canopy to take advantage of its “disruptive” portfolio of cannabis beverages and its research into marijuana’s medical applications.“All these things are mega medium- to long-term outcomes, and Constellation has the best seat in the house to see that,” Linton said. “What they may say is, ‘We can actually buy the whole thing and about two years after we buy it, sell the medical division for more than we paid for the whole thing.”’Given Constellation’s “opportunistic mindset,” Cantor Fitzgerald analyst Pablo Zuanic said he’d assign more than two-thirds probability that it will bid for the rest of Canopy in the near term. “On the argument of an improving outlook for the cannabis industry, we think STZ could justify a deal,” he wrote in a note, using Constellation’s stock ticker.However, it won’t be an easy decision given the state of Constellation’s balance sheet, the earnings-per-share dilution that would result from a deal and a likely near-term hit to its share price, he said.Constellation said in a recent filing that it doesn’t plan to make additional cash contributions to Canopy beyond the possible exercise of its existing warrants.Canopy’s share price is down 63% since its recent high on April 29, and the company has said it won’t generate positive earnings before interest, taxes, depreciation and amortization until fiscal 2022.Klein’s appointment is “another step on Canopy’s path to profitability,” said Bloomberg Intelligence analyst Kenneth Shea. “Klein brings extensive consumer-products industry experience and financial acumen to Canopy during a period of investor anxiety over the company’s struggles to rein in spending and align itself for sustainable Ebitda profitability.”Zekulin will step down on Dec. 20, Canopy said. Klein will be replaced as chairman when he becomes CEO.(Updates stock price in paragraph 3, adds comments from Bruce Linton in paragraphs 5-6)To contact the reporter on this story: Kristine Owram in New York at kowram@bloomberg.netTo contact the editors responsible for this story: Brad Olesen at bolesen3@bloomberg.net, Courtney Dentch, David ScanlanFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week
    Benzinga

    Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

    Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week Welcome to the  Cannabis Countdown . In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for ...

  • UPDATE 3-Constellation tightens grip on Canopy with CEO appointment
    Reuters

    UPDATE 3-Constellation tightens grip on Canopy with CEO appointment

    Constellation Brands Inc finance head David Klein will take over in January as chief executive officer of pot producer Canopy Growth Corp, hardening up the Corona beer maker's control of a company into which it has sunk $4 billion. Klein was appointed Canopy chairman in October after Constellation booked a $430 million net loss related to the company. Linton had said that he was fired from the top job, days after Constellation expressed its disappointment over Canopy's 2018 results.

  • /R E P E A T -- Media Advisory - Canopy Growth Presents Flower Forward Calgary: The Future of Cannabis/
    CNW Group

    /R E P E A T -- Media Advisory - Canopy Growth Presents Flower Forward Calgary: The Future of Cannabis/

    /R E P E A T -- Media Advisory - Canopy Growth Presents Flower Forward Calgary: The Future of Cannabis/

  • Canopy Growth Appoints Constellation CFO As The Cannabis Company's New CEO
    Benzinga

    Canopy Growth Appoints Constellation CFO As The Cannabis Company's New CEO

    Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced Monday that David Klein has been hired as the company’s new CEO, effective Jan. 14, 2020. As previously announced, interim CEO Mark Zekulin will resign from the position and also from his seat on the company’s board of directors, effective Dec. 20. Klein has sharpened his leadership skills for the last 14 years at Constellation Brands (NYSE: STZ), covering CPG and beverage alcohol industries.

  • Reuters

    Constellation tightens grip on Canopy with CEO appointment

    Klein was appointed Canopy chairman in October after Constellation booked a $430 million net loss related to the company. Linton had said that he was fired from the top job, days after Constellation expressed its disappointment over Canopy's 2018 results. Canopy's U.S.-listed shares rose 4.5% to $19.49 in trading before the bell, while Constellation shares were little changed.

  • MarketWatch

    Canopy Growth names Constellation Brands' CFO David Klein as CEO, effective Jan. 14

    Canopy Growth Corp. said Monday it has named David Klein, chief financial officer at its biggest shareholder, Constellation Brands Inc. , as its chief executive officer, effective Jan. 14. Klein will replace current CEO Mark Zekulin, who will be stepping down and resigning his board seat within a year. Canopy is the cannabis sector market leader, thanks to a $4 billion investment from Corona beer brewer Constellation last year. The company ousted Zekulin's co-CEO and Founder Bruce Linton in July, and initiated a CEO search. Canopy's U.S.-listed shares rose 1.9% premarket, but are down 31% in 2019, while the ETFMG Alternative Harvest ETF has fallen 32% and the S&P 500 has gained 25%.

  • Market Exclusive

    Market Morning: Disney Epilepsy Warning, Banana Fiasco, Constellation Cannabis Concerns

    Disney’s Star Wars Episode IX Discriminates Against Epileptics Disney’s (NYSE:DIS) new Star Wars movie Star Wars: The Rise of Skywalker, could be dangerous for those suffering from epileptic seizures. The Epilepsy Foundation said on Friday that Walt Disney Studios had reached out to notify the epilepsy community of sustained flashing lights in the movie that […]The post Market Morning: Disney Epilepsy Warning, Banana Fiasco, Constellation Cannabis Concerns appeared first on Market Exclusive.